Document 0876
 DOCN  M9650876
 TI    [HIV seropositivity in blood donations: prevalence, residual risk and
       epidemiology. The Retrovirus Work Group of the French Society of Blood
       Transfusion]
 DT    9605
 AU    Courouce AM; Institut National de la Transfusion Sanguine, Paris.
 SO    Transfus Clin Biol. 1995;2(5):357-63. Unique Identifier : AIDSLINE
       MED/96151338
 AB    As it has been observed since the beginning of anti-HIV screening in
       blood donations, the rate of seropositive donations has been still
       decreasing during these 4 last years: 0.090/1000 in 1991 to 0.042/1000
       in 1994. This decrease has been observed in blood donations from
       first-time donors (0.38 to 0.17/1000) and from regular donors (0.060 to
       0.030/1000). However, the residual risk from cellular components, such
       as it is estimated, seems to be stable. The proportion of blood
       donations positive for both anti-HIV and anti-HBc was constantly
       decreasing from year to year: 63% between 1985 and 1988 and 25% in 1994.
       The repartition of seropositive donors into sex, ages and at-risk groups
       during this recent period was the same as previously observed.
 DE    Adolescence  Adult  Biological Markers/BLOOD  *Blood Donors  Blood
       Transfusion/ADVERSE EFFECTS  English Abstract  Female  Hepatitis B
       Antibodies/BLOOD  Hepatitis B Core Antigens/IMMUNOLOGY  Human  HIV
       Seropositivity/*EPIDEMIOLOGY/TRANSMISSION  *HIV Seroprevalence  Male
       Risk Factors  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).